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Background/aim: Adnexal torsion is a common gynaecological emergency, and considered to be a problem mostly in reproductive-age
women. To evaluate the effect of metformin and detorsion treatment on reducing ovarian reserve in an ovarian torsion model.
Materials and methods: Twenty-four nonpregnant, Wistar Hannover rats were included in the study. Animals were divided into 3
groups: the control group, the detorsion only group, and the metformin + detorsion group. The first group received only laparotomy.
In the second group, ovaries were fixed to the abdominal wall after performing 360° ovarian torsion, followed by detorsion after a 3-h
period of ischemia. The third group underwent the same torsion and detorsion procedures as the second group, and received 50 mg/kg
metformin by gavage for 14 days. Ovarian damage scores, follicle counts, and AMH levels were evaluated.
Results: The total damage score was significantly increased in the detorsion only group compared to the metformin+detorsion and
control groups. Pre-operative/post-operative AMH decreases were statistically significant in negative direction in the detorsion only
group when compared to the metformin+detorsion and control groups (P = 0.001).
Conclusion: Metformin+detorsion treatment may be effective in protecting the ovarian reserve after ovarian torsion.
Key words: anti-Müllerian hormone, detorsion, metformin, ovarian reserve, ovarian torsion

1. Introduction
Ovarian torsion is defined as partial or complete rotation of
the ovary around its pedicle or vascular axis [1,2]. Torsion
of adnexal structures can result in massive parenchymal
congestion, infarcts, and haemorrhagic necrosis after
arterial and venous blockade [2]. Adnexal torsion is the
fifth most common gynaecological emergency, with a
reported incidence of 2.7% in the United States [3,4].
Although ovarian torsion is considered to be a problem
mostly in reproductive-aged women, it can occur from
early foetal life to the postmenopausal period [5].
Owing to its nonspecific symptoms, such as nausea,
vomiting, and pelvic pain, there is almost always a delay
in diagnosis. Ultrasound imaging may be helpful in the
diagnosis. However, even Doppler sonography is successful
in diagnosing only 40% of surgically confirmed cases [6].
This difficulty in diagnosing ovarian torsion leads to loss

of ovarian tissue and function. A total of 50%–90% of
adnexal torsion cases are caused by physiological cysts,
endometriosis, dermoid cysts, fibromas, and other benign
or malignant ovarian neoplasms [7,8]. Traditionally,
the suggested treatment is salphingoophorectomy or
oophorectomy. However, evaluating tissue perfusion
intraoperatively and leaving the tissue in its anatomical
place is a common and reliable approach, especially for
reproductive-aged women [9,10]. There is no relation
between the variable colours (purple to black) of the
adnexal structures and tissue viability.
It has also been reported that detorsion of the adnexa
has no effect on the risk of thromboembolism [10, 11]. After
the detorsion of tissue, ischemia may resolve, resulting
in tissue recirculation and reperfusion. However, this
procedure also has adverse effects, including reperfusion
injury [12]. Ischemia followed by reperfusion of the tissue
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releases reactive oxygen species (ROS), which, together
with its associated products, damage cell membranes and
worsen tissue functions. There have also been studies
reporting the benefits of antioxidant therapy for ischemiareperfusion injury in different tissue types. Hartmann
et al. reported that pretreatment with glutamine which,
is well known as an antioxidant, is useful in protection
against oxidative damage in the intestine and liver in an
experimental study [13].
Metformin, a biguanide group agent, is used as an
insulin sensitizer for the treatment of diabetes. In a few
reported studies, it has been speculated that metformin has
antioxidant and anti-inflammatory effects [14]. It enhances
the use of glucose in peripheral tissues and increases cyclic
adenosine mono phosphate kinase (AMPK) which plays a
major regulatory role in the balance of cellular energy by
switching cells from the anabolic state to the catabolic state
[15]. It has been reported that metformin has an ability to
decrease inflammation by reducing ROS, by decreasing the
activity of mitochondrial complex I [16]. Besides, its antiinflammatory effects rely on inhibition of the activation of
NF-κB and activation of AMPK [17].
In this study, we aimed to evaluate the efficacy of
metformin therapy in addition to detorsion for preserving
ovarian reserve and ovarian structure.
2. Materials and methods
This study was performed at a tertiary medical centre
named Bağcılar Training and Research Hospital
Experimental Laboratory, İstanbul after the approval by
the ethics committee of the animal studies of the same
institution. A power analysis was performed to calculate
the minimum sample size required for animal studies,
considering anti-Müllerian hormone (AMH) results,
(alpha error: 0.05; beta: 0.8) suggested that ≥12 ovaries
were required for each study group. Because 10% of study
animals are lost during procedures, we included 16 ovaries
per surgery group. We planned to include 8 rats in each
group, and 24 female, nonpregnant, Wistar Hannover
rats (reproductive age, 8 weeks; weight, 180–260 g; with 2
consecutive 4-day-long oestrous cycles proven with daily
vaginal smears) were finally included in the study. All rats
were kept in standard laboratory conditions (minimum
cage area, 350 cm2; minimum cage height, 14 cm; fed ad
libitum with rat pellets; mean temperature, 21 °C; 12-h
day-night period; mean humidity, 50%).
Three groups (n = 8 for each group) were generated
through a computer-based randomization. Group 1 was
the control group, which underwent laparotomy only;
group 2 was the detorsion only group; and group 3 was
the detorsion + metformin group. General anesthesia
was induced with 50 mg/kg intramuscular ketamine
hydrochloride (10% Ketasol; Richter Pharma AG,
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Weis, Austria) and 5 mg/kg intramuscular xylazine
hydrochloride (2% Rompun; Bayer HealthCare LCC,
Shawnee, KS, USA) in sterile conditions. The rat was laid
on the operation table in the supine position. Before the
surgeries, 1 mL of blood samples were drawn from the
jugular vein for rat AMH analysis. The operation field
was shaved, and 10% povidone-iodine solution was
used for antisepsis. The uterine horns and both ovaries
were exposed after making a 3-cm midline abdominal
incision. The control group underwent laparotomy
only with no extra intervention; the detorsion only and
metformin and detorsion groups both had the ovaries
rotated 360° and fixed to the abdominal side wall with
4–0 vicryl (Figure 1). The peritoneum was closed with
4–0 polyglycolic acid sutures, and 3–0 silk was used for
skin closure.
After each operation, the operation field was
sterilized, and the other procedure was started after 15
min. A 3-h-long torsion and detorsion period were
selected considering the data from previous study
demonstrating that histologic changes in the ovaries
can occur after 3 h of continuous ischemia [18]. After a
3-h ischemia period, second operations were performed
with the induction of the same anaesthesia (Figure 2).
The ovaries in the detorsion only and metformin and
detorsion groups were released from the abdominal side
wall and detorsioned, and the abdominal incision was
closed. After the operations, 1 rat in each group died of
intolerance of the second dose of anaesthesia. The study
continued with 7 rats in each group. Other than the other
groups, only metformin+detorsion group received 50
mg/kg/day metformin (Glucophage 500 mg tablet; Merc
İlaç Sanayi A.Ş, İstanbul, Turkey) for 14 days by gavage.
After 3 oestrous cycles, which correspond to three
menstrual cycles in humans, 1 mL of blood samples
were drawn from the jugular vein of the each rat for a
second AMH analysis. Laparotomy was performed in
each rat, and bilateral oophorectomies were performed
for histopathological analysis. Each rat was euthanized by
means of cervical dislocation after the operations.
2.1. Histopathology
The excised ovaries were kept in 10% formalin solution
and evaluated after 24 h by a pathologist from Bakırköy
Dr Sadi Konuk Training and Research Hospital who was
blinded to the study groups. The tissue samples were
embedded in paraffin blocks, cut into 4-μm slices, and
prepared for haematoxylin and eosin staining. Follicle
counting was performed according to a study by Ozler
et al. [19]. At least 5 microscopic areas were evaluated
with light microscopy (Nikon Eclipse 80i AS Amstelveen,
The Netherlands). The follicles were divided into 4
groups according to diameter: primordial (<20 μm),
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Figure 1. The black arrow shows exposed ovary and uterine
horn. The adnexa is rotated 360° clockwise, and then sutured to
the abdominal wall.

Figure 2. The black arrow shows torsioned ovary after 3h
ischemia period.

preantral (20–220 μm), small antral (221–310 μm), and
large antral (311–370 μm). Atretic follicles were defined
according to the study by Osman et al. [20]. The ovarian
damage score was evaluated on the basis of the following
parameters: follicle cell degeneration, vascular congestion,
haemorrhage, and inflammation for both ovaries (0: none,
1: mild, 2: moderate, 3: severe) (Figure 3,4).
2.2. AMH analysis
All blood samples were centrifuged for 10 min at 4000 rpm
to obtain serum samples. The samples were kept at –80 °C
in Eppendorf tubes until analysis. Serum AMH levels were
analysed with an automatic ELISA kit (Omentin ELISA
kit; Hangzhou Eastbiopharm Co., Hangzhou, China).

Figure 3. The black arrows show haemorrhage area with red
blood cells. H&Ex200

Figure 4. The black arrows show degenerated granulosa cells.
H&Ex200

2.3. Statistical analysis
Statistical analyses were performed by using NCSS
(Number Cruncher Statistical System) 2007 statistical
software (Kaysville, UT, USA). Descriptive statistical
analysis, such as mean, standard deviations, and one-way
analysis of variance, was used for continuous data with a
normal distribution. A valid chi-squared test is used for
categorical variables. The Tukey test was used for post hoc
analysis of normally distributed parametric data. A paired
sample t-test was used to evaluate the preoperative and
postoperative AMH levels. The Kruskal–Wallis test was
used to compare continuous data with skewed distribution,
and the Dunn test was used for post hoc analysis. The chi-
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square test was used for qualitative data. P values of <0.05
were considered statistically significant.

in the total damage score between the control group
and the metformin and detorsion group. There was no
statistically significant difference in vascular congestion
and haemorrhage scores among the study groups (Table
1, 2).
The study groups were also evaluated for follicle
counts. There was a statistically significant difference in
the numbers of preantral follicles, large antral follicles,
and corpora lutea among the control, detorsion only, and
metformin and detorsion groups (P = 0.0001, P = 0.041, P
= 0.023, respectively) (Table 3). The preantral follicle, large
antral follicle, and corpora lutea counts were lower in the
detorsion only group than in the control and metformin
and detorsion groups. There was no significant difference
in preantral follicle, large antral follicle, and corpora lutea
counts between the control group and the metformin and
detorsion group (Table 4). There was also no significant
difference in the counts of primordial, small antral, and
atretic follicles between the study groups. There was a
statistically significant difference in the preoperative
vs. postoperative anti-Müllerian hormone (AMH)
level changes between the control, detorsion only, and

3. Results
The ovarian damage scores were evaluated for each rat,
and there was a statistically significant difference in the
follicular damage scores between the control, detorsion
only, and metformin and detorsion groups (P = 0.048).
There was a mildly increased damage score in the control
and metformin and detorsion groups. However, a severe
score was observed in the detorsion only group, which
was statistically significant in comparison with the other
groups. There was also a statistically significant difference
in the inflammation scores among the study groups (P =
0.002). No inflammation was observed in the control and
metformin and detorsion groups. However, moderate
and severe scores were observed in the detorsion only
group. The total damage scores were statistically different
among the study groups. The total damage scores were
higher in the detorsion only group than in the control and
metformin and detorsion groups (P = 0.005 and P = 0.021,
respectively). However, there was no statistical difference

Table 1. Follicle cell degeneration, vascular congestion, haemorrhage, inflammation, and total damage scores between study
groups.

Follicle cell
degeneration

Vascular congestion

Haemorrhage

Inflammation

*Total damage score

Control Group
(n,%)

Detorsion
Only Group (n,%)

Metformin and
P- value
detorsion Group (n,%)

None

1

7.14%

2

14.29%

2

14.29%

Mild

8

57.14%

5

35.71%

7

50.00%

Moderate

5

35.71%

2

14.29%

5

35.71%

Severe

0

0.00%

5

35.71%

0

0.00%

None

1

7.14%

0

0.00%

0

0.00%

Mild

9

64.29%

5

35.71%

5

35.71%

Moderate

4

28.57%

6

42.86%

9

64.29%

Severe

0

0.00%

3

21.43%

0

0.00%

None

2

14.29%

4

28.57%

2

14.29%

Mild

10

71.43%

3

21.43%

10

71.43%

Moderate

2

14.29%

3

21.43%

1

7.14%

Severe

0

0.00%

4

28.57%

1

7.14%

None

12

85.71%

4

28.57%

11

78.57%

Mild

2

14.29%

2

14.29%

3

21.43%

Moderate

0

0.00%

6

42.86%

0

0.00%

Severe

0

0.00%

2

14.29%

0

0.00%

3.64 ± 1.34

6.5 ± 3.32

Chi-square test, *One Way ANOVA
(0: none, 1: mild, 2: moderate, 3: severe).
P-value of <0.05 was considered to be statistically significant.
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4.14 ± 1.46

0.004

0.048

0.069

0.075

0.002
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Table 2. Tukey HSD test P-values for the total damage scores of the study groups.
Tukey HSD test

Total damage score

Control group/detorsion only group

0.005

Control group/Metformin and detorsion group

0.825

Detorsion only group/Metformin and detorsion group

0.021

Table 3. Primordial, preantral, small antral, large antral and atretic follicle counts, and corpora lutea counts of the
study groups.

Primordial follicle
Preantral follicle
Small antral follicle
Large antral follicle
Corpora lutea
Atretic follicle

Mean ± SD
Mean ± SD
(Range)
Mean ± SD
(Range)
Mean ± SD
(Range)
Mean ± SD
(Range)
Mean ± SD
(Range)

Control
group

Detorsion
only group

Metformin and
detorsion group

4 ± 2.18
(2–5)
3.57 ± 1.65
(2–5)
4 ± 2.48
(3–4)
10.36 ± 5.03
(7.25–14.25)
6.36 ± 3.59
(4.75–9)
23.79 ± 17.5
(15–25.75)

2.86 ± 4.22
(0–4)
0.79 ± 0.89
(0–2)
2.57 ± 2.44
(0–4)
5.57 ± 5.17
(0–9.25)
2.93 ± 3.71
(0–5)
26.36 ± 14.14
(14.75–39.5)

4 ± 2.6
(1.75–5.25)
3 ± 2.04
(1–3.5)
3.21 ± 1.76
(1.75–5)
10.14 ± 5.53
(4–14.25)
5.93 ± 3.77
(2.8–10)
23.57 ± 9.94
(13–31)

P-value
0.112
0.0001
0.291
0.041
0.023
0.502

Kruskal–Wallis test
SD: Standard deviation
P-value of <0.05 was considered to be statistically significant.
Table 4. Dunn’s test P-values for the preantral follicle, large antral follicle, and corpora lutea counts of the
study groups.
Dunn’s test

Preantral
follicle

Large antral
follicle

Corpora
lutea

Control group/detorsion only group

0.0001

0.022

0.008

Control group/Metformin and detorsion group

0.315

0.818

0.889

Detorsion only group/Metformin and detorsion group

0.001

0.04

0.037

metformin and detorsion groups (P = 0.0001) (Table 5).
The detorsion only group showed negatively statistically
different changes in this parameter compared with the
other groups (P = 0.001) (Table 6). However, there was
no statistically significant difference for this parameter
between the control group and the metformin and
detorsion group.
4. Discussion
In present study, our aim was to evaluate the efficacy
of metformin considering its antioxidant and

antiinflammatory benefits in addition to detorsion for
preserving ovarian reserve and ovarian structure and we
revealed that Metformin and detorsion treatment may be
effective in protecting the ovarian reserve after ovarian
torsion.
Excision of the adnexa is the traditional approach for
treating ovarian torsion. However, recent studies do not
recommend this treatment approach, considering the
importance of the ovary for women of reproductive age
[21,22]. Moreover, there is still some concern about leaving
necrotic tissue in situ and complications such as infection,
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Table 5. Preoperative and postoperative serum AMH results of the study groups.
Control group

Detorsion
only group

Metformin and
detorsion group

P- value*

Preoperative AMH

4.34 ± 1.43

5.87 ± 1.02

3.65 ± 1.42

0.0001

Postoperative AMH

3.22 ± 1.39

1.78 ± 1.82

2.54 ± 1.18

0.048

P-value ¶

0.0001

0.0001

0.0001

Pre-Postoperative AMH alteration

1.12 ± 0.24

4.09 ± 1.14

1.12 ± 0.69

0.0001

AMH (anti-Müllerian hormone)
¶
paired sample t test *Kruskal–Wallis test
Note: Values are expressed as mean ± SD
Table 6. Tukey HSD test P-values for the preoperative, postoperative serum AMH results, and pre-postoperative AMH
alteration of the study groups.
Tukey HSD test

Preoperative
AMH

Postoperative
AMH

Pre-Postoperative
AMH alteration

Control group/detorsion only group

0.01

0.037

0.0001

Control group/Metformin and detorsion group

0.349

Detorsion only group/Metformin and detorsion group

0.001

0.450
0.380

0.998
0.0001

AMH (anti-Müllerian hormone)

increased risk of malignancy, and systemic problems such
as pulmonary embolism or thrombosis in other organs
[23]. In our study, our main goal was to determine the
ovarian reserve after ovarian detorsion and we did not
observe any signs of pelvic infection.
Ischemia-reperfusion injury is generally explained by
the hypothesis that there is an accumulation of neutrophils
and thrombocytes due to the activated complement and
other inflammatory components around the inflammation
site. This aggregation of inflammatory cells enhances the
production of ROS. In addition, glycolysis, increased lactic
acid concentration, and intracellular Ca accumulation
result in decreased intracellular pH and acidosis. This
results in increased intracytoplasmic lysozyme enzymes
causing damage to proteins and the cell membrane [24].
Enzymes such as glutathione peroxidase and catalase play
a protective role against cellular ROS. Moreover, cysteine,
glutathione, ceruloplasmin, and vitamins A/C/E also act
as intracellular and extracellular antioxidants and protect
the cell structure from ROS [25]. The balance between
oxidants and antioxidants is lost in ischemia-reperfusion
injury. In this case, enzymes such as lipid peroxidase,
superoxide dismutase, inducible nitric oxide synthase,
and myeloperoxidase levels increase [26,27]. In a study
by Bostancı et al. [28], granulocyte colony-stimulating
factor (G-CSF), a glycoprotein commonly used to
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treat neutropenia by mobilizing bone marrow-derived
hematopoietic cells into peripheral blood, was used in
an experimental model of ischemia-reperfusion injury.
The authors administered intraperitoneal injections of
G-CSF (100 IU/kg) and evaluated the mean total oxidant
status (TOS), oxidative stress index (OSI), and the total
histopathological scores of rats with ischemia-reperfusion
injury. G-CSF administration decreased the mean TOS and
OSI levels significantly when compared with the controls.
Moreover, there was a decrease in total histopathological
scores for rats conservatively treated with G-CSF compared
with the control groups. Bakacak et al. [29] used plateletrich plasma, which is clinically used to promote wound
healing, in an experimental ischemia-reperfusion injury
model. They found that the TOS, OSI, and total ovarian
histopathological scores were higher in the nontreated
group than in the group treated with 0.5 mL platelet-rich
plasma. Halici et al. [27] evaluated the long-acting calcium
channel blocker amlodipine in an experimental model of
ischemia-reperfusion injury. They administered 3 and 5
mg/kg doses of amlodipine, and concluded that amlodipine
is effective in preventing ovarian damage. Kumtepe et
al. [30] studied the angiotensin 2 type 1 receptor blocker
telmisartan, which is used as an antihypertensive agent in
daily practice, in an experimental ischemia-reperfusion
model. Telmisartan, at doses of 10 and 20 mg/kg,
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reduced ROS, inducible nitric oxide synthase activity,
and myeloperoxidase levels compared with no treatment
and all other tested drug doses. In the line with our
study, Sayan et al. evaluated the effect of metformin on
ovarian ischemia-reperfusion injury in an experimental
torsion/detorsion rat model. They used the glutathioneto-oxidized-glutathione ratio, malondialdehyde (MDA),
and caspase-3 activation to determine tissue damage in
addition to ovarian histopathology. According to their
results metformin was effective in regards to attenuating
ovarian ischemia-reperfusion injury [31]. All of the studies
mentioned above are based on protecting the cell from
these ROS [32]. In our study, we also tried to evaluate
antioxidant and antiinflammatory effect of metformin
after ovarian detorsion. Previous ischemia-reperfusion
studies performed with metformin in different tissues
have shown that metformin protects tissues by reducing
lipid peroxidase, MDA, ROS, and inflammatory cytokines
[33,34]. Furthermore, it has been reported that metformin
relieves the inflammatory responses after cardiac ischemia
by activating adenosine monophosphate-activated protein
kinase (AMPK). AMPK agonists also inhibit inflammatory
factors such as tumour necrosis factor-α, interleukin-6,
and cyclooxygenase-2 [35,36]. In our study, we found that

the follicular damage scores and inflammatory damage
scores were significantly better in the group that received
metformin than in the group that received detorsion
only. We may postulate that this effect results from the
antioxidant and antiinflammatory effects of the drug.
The status of the ovarian reserve can be determined
on the basis of the antral follicular counts on ultrasound,
serum day 3 follicle-stimulating hormone and oestradiol
levels, clomiphene citrate challenge test, and anti-Müllerian
hormone (AMH) levels [37]. In addition to the study by
Sayan et al. [31], in our study, we evaluated the status of
ovarian reserve by measuring AMH, which is released
from preantral and small antral follicles. We found that the
preoperative to postoperative decrease was greater in the
detorsion only group than in the control and metformin
and detorsion groups.
As a limitation of our study, the duration of postoperative
period may not be enough to determine ovarian damage.
In addition, reperfusion injury may be evaluated with
oxidative stress markers in serum or tissue samples. These
limitations may be considered in future studies.
Informed consent
None (experimental animal study)

References
1.

Huchon C, Fauconnier A. Adnexal torsion: a literature
review. European Journal of Obstetrics & Gynecology and
Reproductive Biology 2010; 150 (1): 8-12. doi: 10.1016/j.
ejogrb.2010.02.006

8.

Lee EJ, Kwon HC, Joo HJ, Suh JH, Fleischer AC. Diagnosis of
ovarian torsion with color Doppler sonography: depiction of
twisted vascular pedicle. Journal of Ultrasound in Medicine
1998; 17 (2): 83-89. doi: 10.7863/jum.1998.17.2.83

2.

Vijayalakshmi K, Reddy GM, Subbiah VN, Sathiya S, Arjun
B. Clinico-pathological profile of adnexal torsion cases: a
retrospective analysis from a tertiary care teaching hospital.
Journal of Clinical and Diagnostic Research 2014; 8(6): OC04–
OC7. doi:10.7860/JCDR/2014/8167.4456

9.

Mashiach S, Bider D, Moran O, Goldenberg M, Ben-Rafael
Z. Adnexal torsion of hyperstimulated ovaries in pregnancies
after gonadotropin therapy. Fertility and Sterility 1990; 53 (1):
76-80. doi: 10.1016/s0015-0282(16)53219-1

3.

Hibbard LT. Adnexal torsion. American Journal of Obstetrics
& Gynecology 1985; 152 (4): 456-461. doi: 10.1016/s00029378(85)80157-5

10.

Oelsner G, Bider D, Goldenberg M, Admon D, Mashiach S.
Long-term follow-up of the twisted ischemic adnexa managed
by detorsion. Fertility and Sterility 1993; 60 (6): 976-979. doi:
10.1016/s0015-0282(16)56395-x

4.

Houry D, Abbott JT. Ovarian torsion: a fifteen-year review.
Annals of Emergency Medicine 2001; 38 (2): 156-159. doi:
10.1067/mem.2001.114303

11.

Wagaman R, Williams RS. Conservative therapy for adnexal
torsion. A case report. Journal of Reproductive Medicine 1990;
35 (8): 833-834.

5.

Genç M, Şahin N, Karaarslan S, Güçlü S. The evaluation of
clinical, radiological, pathological profile of ovarian torsion
cases. Yeni Tıp Dergisi 2015; 32: 79-82.

12.

Rangan U, Bulkley GB. Prospects for treatment of free radicalmediated tissue injury. British Medical Bulletin 1993; 49 (3):
700-718. doi: 10.1093/oxfordjournals.bmb.a072641

6.

Ekin M, Kaya C, Cengiz H, Yasar L, Dogan K. A rare case:
ruptured ectopic pregnancy with contralateral adnexal torsion.
Bakırköy Tıp Dergisi 2015; 11: 29-32.

13.

7.

Pedrosa I, Zeikus EA, Levine D, Rofsky NM. MR imaging of
acute right lower quadrant pain in pregnant and nonpregnant
patients. Radiographics 2007; 27 (3): 721-753. doi: 10.1148/
rg.273065116

Hartmann RM, Licks F, Schemitt EG, Colares JR, do Couto
Soares M et al. Protective effect of glutamine on the main and
adjacent organs damaged by ischemia-reperfusion in rats.
Protoplasma 2017; 254 (6): 2155-2168. doi: 10.1007/s00709017-1102-3

461

KARAKAŞ et al. / Turk J Med Sci
14.

Hattori Y, Suzuki K, Hattori S, Kasai K. Metformin inhibits
cytokine-induced nuclear factor kappaB activation via AMPactivated protein kinase activation in vascular endothelial
cells. Hypertension 2006; 47 (6): 1183-1188. doi: 10.1161/01.
HYP.0000221429.94591.72

25.

Kaya C, Turgut H, Cengiz H, Turan A, Ekin M et al. Effect of
detorsion alone and in combination with enoxaparin therapy
on ovarian reserve and serum antimüllerian hormone levels
in a rat ovarian torsion model. Fertility and Sterility 2014; 102
(3): 878-884.e1. doi: 10.1016/j.fertnstert.2014.06.007

15.

Zhou G, Myers R, Li Y, Chen Y, Shen X et al. Role of AMPactivated protein kinase in mechanism of metformin action.
Journal of Clinical Investigation 2001; 108 (8): 1167-1174.
doi: 10.1172/JCI13505

26.

16.

Esteghamati A, Eskandari D, Mirmiranpour H, Noshad
S, Mousavizadeh M et al. Effects of metformin on markers
of oxidative stress and antioxidant reserve in patients with
newly diagnosed type 2 diabetes: a randomized clinical
trial. Clinical Nutrition 2013; 32 (2): 179-185. doi: 10.1016/j.
clnu.2012.08.006

Yigiter M, Halici Z, Odabasoglu F, Keles ON, Atalay F et al.
Growth hormone reduces tissue damage in rat ovaries subjected
to torsion and detorsion: biochemical and histopathologic
evaluation. European Journal of Obstetrics & Gynecology and
Reproductive Biology 2011; 157 (1): 94-100. doi: 10.1016/j.
ejogrb.2011.02.012

27.

Halici Z, Karaca M, Keles ON, Borekci B, Odabasoglu F et al.
Protective effects of amlodipine on ischemia-reperfusion injury
of rat ovary: biochemical and histopathologic evaluation.
Fertility and Sterility 2008; 90 (6): 2408-2415. doi: 10.1016/j.
fertnstert.2007.10.007

28.

Bostancı MS, Bakacak M, İnanc F, Yaylalı A, Serin S et al.
The protective effect of G-CSF on experimental ischemia/
reperfusion injury in rat ovary. Archives of Gynecology and
Obstetrics 2016; 293 (4): 789-795. doi: 10.1007/s00404-0153878-8

29.

Bakacak M, Bostanci MS, İnanc F, Yaylali A, Serin S et al.
Protective Effect of Platelet Rich Plasma on Experimental
Ischemia/Reperfusion Injury in Rat Ovary. Gynecologic
and Obstetric Investigation 2016; 81 (3): 225-231. doi:
10.1159/000440617

30.

Kumtepe Y, Odabasoglu F, Karaca M, Polat B, Halici MB et al.
Protective effects of telmisartan on ischemia/reperfusion injury
of rat ovary: biochemical and histopathologic evaluation.
Fertility and Sterility 2010; 93 (4): 1299-1307. doi: 10.1016/j.
fertnstert.2008.12.016

31.

Dayangan Sayan C, Karaca G, Sema Ozkan Z, Tulmac OB, Isik
AC et al. What is the protective effect of metformin on rat ovary
against ischemia-reperfusion injury? Journal of Obstetrics and
Gynaecology Research 2018; 44 (2): 278-285. doi: 10.1111/
jog.13524

32.

Taskin O, Birincioglu M, Aydin A, Buhur A, Burak F et al.
The effects of twisted ischaemic adnexa managed by detorsion
on ovarian viability and histology: an ischaemia-reperfusion
rodent model. Human Reproduction 1998; 13 (1O): 28232827. doi: 10.1093/humrep/13.10.2823

Coll B, van Wijk JP, Parra S, Castro Cabezas M, Hoepelman IM
et al. Effects of rosiglitazone and metformin on postprandial
paraoxonase-1 and monocyte chemoattractant protein-1
in human immunodeficiency virus-infected patients with
lipodystrophy. European Journal of Pharmacology 2006; 544
(1-3): 104-110. doi: 10.1016/j.ejphar.2006.06.014

33.

23.

Borekci B, Gundogdu C, Altunkaynak BZ, Calık
M, Altunkaynak ME et al. The protective effect of
dehydroepiandrosterone on ovarian tissues after torsiondetorsion injury: a stereological and histopathological study.
Eurasian Journal of Medicine 2009; 41 (1): 22-27.

Detaille D, Guigas B, Chauvin C, Batandier C, Fontaine E et
al. Metformin prevents high-glucose-induced endothelial
cell death through a mitochondrial permeability transitiondependent process. Diabetes 2005; 54 (7): 2179-2187. doi:
10.2337/diabetes.54.7.2179

34.

24.

Li C, Jackson RM. Reactive species mechanisms of cellular
hypoxia-reoxygenation injury. The American Journal of
Physiology: Cell Physiology 2002; 282 (2): C227-C241. doi:
10.1152/ajpcell.00112.2001

Gómez-García A, Martínez Torres G, Ortega-Pierres LE,
Rodríguez-Ayala E, Alvarez-Aguilar C. Rosuvastatin and
metformin decrease inflammation and oxidative stress in
patients with hypertension and dyslipidemia. Revista Española
de Cardiología 2007; 60 (12): 1242-1249. doi: 10.1157/13113929

17.

18.

Li SN, Wang X, Zeng QT, Feng YB, Cheng X et al. Metformin
inhibits nuclear factor kappaB activation and decreases serum
high-sensitivity C-reactive protein level in experimental
atherogenesis of rabbits. Heart Vessels 2009; 24 (6): 446-453.
doi: 10.1007/s00380-008-1137-7
Oral A, Odabasoglu F, Halici Z, Keles ON, Unal B et al.
Protective effects of montelukast on ischemia-reperfusion
injury in rat ovaries subjected to torsion and detorsion:
biochemical and histopathologic evaluation. Fertility
and Sterility 2011; 95 (4): 1360-1366. doi: 10.1016/j.
fertnstert.2010.08.017

19.

Ozler A, Turgut A, Soydinç HE, Sak ME, Evsen MS et al. The
biochemical and histologic effects of adnexal torsion and
early surgical intervention to unwind detorsion on ovarian
reserve: an experimental study. Reproductive Science 2013;
20 (11): 1349-1355. doi: 10.1177/1933719113485300

20.

Osman P. Rate and course of atresia during follicular
development in the adult cyclic rat. Journal of Reproduction
and Fertility 1985; 73 (1): 261-270. doi: 10.1530/jrf.0.0730261

21.

Chen M, Chen CD, Yang YS. Torsion of the previously normal
uterine adnexa. Evaluation of the correlation between the
pathological changes and the clinical characteristics. Acta
Obstetricia et Gynecologica Scandinavica 2001; 80 (1): 58-61.
doi: 10.1034/j.1600-0412.2001.800111.x

22.

462

KARAKAŞ et al. / Turk J Med Sci
35.

Ouslimani N, Peynet J, Bonnefont-Rousselot D, Thérond P,
Legrand A et al. Metformin decreases intracellular production
of reactive oxygen species in aortic endothelial cells. Metabolism
2005; 54 (6): 829-834. doi: 10.1016/j.metabol.2005.01.029

36.

Wang ZS, Liu XH, Wang M, Jiang GJ, Qiu T et al. Metformin
attenuated the inflammation after renal ischemia/reperfusion
and suppressed apoptosis of renal tubular epithelial cell in rats.
Acta Cirúrgica Brasileira 2015; 30 (9): 617-623. doi: 10.1590/
S0102-865020150090000006

37.

Riggs RM, Duran EH, Baker MW, Kimble TD, Hobeika E et al.
Assessment of ovarian reserve with anti-Müllerian hormone: a
comparison of the predictive value of anti-Müllerian hormone,
follicle-stimulating hormone, inhibin B, and age. American
Journal of Obstetrics & Gynecology 2008; 199 (2): 202.e1-202.
e2028. doi: 10.1016/j.ajog.2008.05.004

463

